Endoscopic Gastrointestinal Placement of Capsule Endoscopy to Investigate the Small Bowel: a Multicentric European Retrospective Series of 630 Procedures in Adult Patients

Salome Ouazana,Peter Baltes,Ervin Toth,Hannah Lüttge,Artur Nemeth,Hanneke Beaumont,Begoña González-Suárez,Phey Shen Lee,Cristina Carretero,Reuma Margalit Yehuda,Luca Elli,Cristiano Spada,Mauro Bruno,Alessandro Mussetto,Pablo Cortegoso Valdivia,Aymeric Becq,Gareth Corbett,Antoine Martin,Alexander Robertson,Robert Benamouzig,Edward Despott,Maria Elena Riccioni,Reena Sidhu,Laura Calavas,Pierre Ellul,Adam Finta,Konstantinos Triantafyllou,Emanuele Rondonotti,Julien Kirchgesner,Alfonso Elosua,Deirdre McNamara,Xavier Dray
DOI: https://doi.org/10.1016/j.gie.2024.01.027
IF: 10.396
2024-01-25
Gastrointestinal Endoscopy
Abstract:Background and aims Small bowel (SB) capsule endoscopy (CE) is a first line procedure for exploring the SB. Endoscopic GastroIntestinal PlacemenT (EGIPT) of SB CE is sometimes necessary. While the experience of EGIPT is large in pediatric populations, we aimed to describe the safety, efficacy and outcomes of EGIPT of SB CE in adult patients. Methods The international CApsule endoscopy REsearch (iCARE) group set up a retrospective multicenter study. Patients over 18 year-old who underwent EGIPT of SB CE before May 2022 were included. Data were collected from medical records and capsule recordings. The primary endpoint was the technical success rate of the EGIPT procedures. Results 630 patients were included (mean age 62.5 years old, 55.9% female) from 39,565 patients (1.6%) issued from 29 centers. EGIPT technical success was achieved in 610 procedures (96.8%). Anesthesia (moderate/deep sedation or general anesthesia) and centers with intermediate or high procedure loads were independent factors of technical success. Severe adverse events occurred in three (0.5%) patients. When technically successful, EGIPT was associated with a high SB CE completion rate (84.4%) and with a substantial diagnostic yield (61.1%). Completion rate was significantly higher when the capsule was delivered in the SB compared to when delivered in the stomach. Conclusion EGIPT of SB CE is highly feasible, safe and comes with high completion rate and diagnostic yield. When indicated, it should rather be performed under anesthesia and the capsule should be delivered in the duodenum rather than in the stomach, for better SB examination outcomes.
gastroenterology & hepatology
What problem does this paper attempt to address?